AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Immuno-oncology market to hit $185.69 billion by 2035.
ByAinvest
Wednesday, Jan 14, 2026 10:47 am ET1min read
BNTX--
CMPX--
IBRX--
ONCY--
OSTX--
The global immuno-oncology market is expected to grow from $35 billion to $185.69 billion by 2035. The genomics revolution is driving this growth, integrating advanced profiling into oncology workflows to identify winning treatments. Oncolytics Biotech, ImmunityBio, OS Therapies, BioNTech, and Compass Therapeutics are among the companies benefiting from this trend. The precision medicine market is projected to reach $537.17 billion by 2035, with investors flocking to targeted therapeutic platforms. FDA accelerated approval frameworks are also serving as a catalyst for growth in the sector.
Ainvest News articles are AI-generated using advanced large language model (LLM) technology designed to analyze and synthesize publicly available data and news. While AI tools assist in producing initial drafts and insights, all AI generated content published on Ainvest is subject to comprehensive human editorial review before publication. A designated human editor reviews, verifies, and approves each article for factual accuracy, coherence, and compliance with AInvest Fintech Inc's editorial and disclosure standards.
Despite these review procedures, the information provided may still contain inaccuracies, incomplete data, or time sensitive references due to the inherent limitations of AI generated analysis and evolving changes. The material is provided strictly for informational and educational purposes and does not constitute personalized investment, legal, or financial advice. Readers should independently verify all facts, figures, and statements before making any decision based on this content.
AInvest Fintech Inc. its affiliates, and partners accept no liability or responsibility for any direct or consequential losses arising from reliance on this content. All articles and analyses are subject to revision, update, or removal without prior notice to maintain accuracy and integrity in our publications.
Comments
No comments yet